Menu
Menu

Events

All members have the option of attending our various HTC-centric events which include:

  • Two in-person member meetings a year (in spring and fall)
  • Regular Webinars educating our members on HTC operations & organizational management, payer relations, regulations and legal updates, and advocacy

Events Search and Views Navigation

Event Views Navigation

Today

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Pfizer on HYMPAVZI: An anti-tissue factor pathway inhibitor

Date: Tuesday, December 17, 2024 Time: 3:00pm - 4:00pm ET         TOPIC: HYMPAVZI: An anti-tissue factor pathway inhibitor OBJECTIVE: To educate attendees on the novel mechanism of action of HYMPAVZI, the Ph3 clinical trial results and indicated dosage and administration. INTENDED AUDIENCE: HCP SPEAKER: Dr. Jennifer Schumacher, PhD, Senior Medical Director, Hemophilia Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from Novo Nordisk – Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs

Date: Wednesday, December 18, 2024 Time: 1:00pm - 2:00pm ET         Title: Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs Description and Session Objectives: To provide a clinical overview of the cost and treatment burden across all hemophilia types, the experience with current therapy, and unmet needs that may be Read the full article...

Featured

🟥 Member Event : 2025 Pharmacists CE Conference

Date: January 22 - 24, 2025 Location: The Westin San Diego Gaslamp Quarter, San Diego, CA 92101 Hemophilia Alliance is proud to announce the 4th Annual Pharmacists CE Conference. The conference is designed specifically for Hemophilia Alliance Member HTC pharmacists with direct responsibility for 340B HTC dispensations. There will be 40 spaces available for the Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from BioMarin on ROCTAVIAN: Improving Patient Outcomes – Latest Data & Support Initiatives

Date: Wednesday, February 19, 2025 Time: 1:00pm - 2:00pm ET       TITLE: ROCTAVIAN: Improving Patient Outcomes - Latest Data & Support Initiatives OBJECTIVE: Join us for a webinar on ROCTAVIAN (valoctocogene roxaparvovec), the groundbreaking gene therapy for severe hemophilia A. This webinar will delve into the latest clinical data updates, showcasing the long-term Read the full article...

Featured

🟥 Member Event : 2025 Spring Members Meeting

Date: March 9 - 11, 2025 Location: Salt Lake City, Utah Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

Featured

🟥 Member Webinar : Hemophilia Alliance Presents – Updates from Washington: Administration and Congressional Actions

Date: Wednesday, March 19th, 2025 Time: 12:00pm - 1:00pm ET WEBINAR TOPIC: Updates from Washington: Administration and Congressional Actions OBJECTIVE: The current status of government funding for fiscal year 2025. The potential impact of the new Administration’s early actions, including Executive Orders, reduction in agency staffing, changes to the regulatory process and how this may Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Takeda on FVIII Portfolio

Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET       TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. INTENDED AUDIENCE: All HTC staff SPEAKER: Anthea Cherednichenko, VP US Hematology Franchise Head Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Novo Nordisk on Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors

Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors OBJECTIVE: To provide a prescribing information overview of the recently FDA approved medication, Alhemo (concizumab-mtci), for patients living with hemophilia A or B with Read the full article...

Featured

🟥 Member Event : 2025 Nurses CE Conference

Date: April 27 - 29, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

Featured

🟥 Member Event : 2025 New HTC Staff Meeting

Date: April 29 - May 1, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Pfizer on Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq)

Date: Tuesday, May 6th, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TOPIC: Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq) OBJECTIVES: Educate attendees on complications and challenges associated with hemophilia, the novel mechanism of action of HYMPAVZI, the BASIS Ph3 clinical trial results and dosage and Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Sanofi – Exploring data and expert perspectives on Qfitlia™ (fitusiran)

Date: Wednesday, May 7th, 2025 Time: 1:00pm - 2:00pm ET       WEBINAR TOPIC: Exploring data and expert perspectives on Qfitlia™ (fitusiran) OBJECTIVE: During this program, we will explore data and expert perspectives on Qfitlia™ (fitusiran), a newly approved prophylactic treatment for patients with hemophilia A and B, with or without inhibitors. SPEAKER: Vanessa Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from BioMarin – A Collaborative Journey – ROCTAVIAN Patient & Provider Perspectives

Date: Tuesday, May 13th, 2025 Time: 1:00pm - 2:00pm ET       WEBINAR TOPIC: A Collaborative Journey - ROCTAVIAN Patient & Provider Perspectives OBJECTIVE: Join us for an insightful webinar exploring the real-world experiences of patients and providers with ROCTAVIAN. Hear firsthand accounts of the treatment journey, from initial consultations and administration to outcomes Read the full article...

About

What We Do
Staff & Consultants
Board Of Directors
History of the HTCs

What We Offer

Services & Tools
Partnerships
Job Postings

Product Guide

By Manufacturers
By Factor Types

News

Latest News
Newsletters
Subscribe

Members

Benefits
Member Map
Events

HANS

HANS For Payer
HANS For Broker

Join Now
Member Login

Contact Us

Join
Member Login

About

Overview
Staff & Consultants
Board Of Directors
History of the HTCs

Services & Tools

Overview
Partnerships
Job Postings

Product Guide

By Manufacturers
By Factor Types

News

News & Blog
Newsletters
Subscribe

Members

Benefits
Alliance Contact Map
Events

HANS

HANS For Payer